This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

24 Mar 2011

Seattle Genetics Strikes Again with $208M ADC Deal with Abbott

Abbott is responsible for research, product development, manufacturing and commercialization of any ADC products under the collaboration.

Seattle Genetics has racked up another collaboration agreement  which involves closely-watched antibody-drug conjugate technology. The red-hot ADC company is pocketing $8 million from Abbott Laboratories, which is promising up to $200 million more as it focuses on a single cancer target.


"This is the second ADC collaboration with a multinational pharmaceutical company that we have announced this year, further illustrating the important role that our ADC technology is poised to play in the treatment of many types of cancer," says Eric Dobmeier, the chie

Related News